What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines
Authors:
- Fabiano A. GomesFGFabiano A. Gomes
- Flavio KapczinskiFKFlavio Kapczinski
- 1 February 2022
- journal article
- review article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 298 (Pt A) , 565-576
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Adherence to Guidelines by French Psychiatrists in Their Real World of Clinical PracticeJournal of Nervous & Mental Disease, 2011
- The Rise and Fall of Gabapentin for Bipolar DisorderMedical Care, 2010
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depressionThe World Journal of Biological Psychiatry, 2010
- Is Anticonvulsant Treatment of Mania a Class Effect? Data from Randomized Clinical TrialsCNS Neuroscience & Therapeutics, 2009
- The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute ManiaThe World Journal of Biological Psychiatry, 2009
- Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic reviewActa Psychiatrica Scandinavica, 2007
- Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of cliniciansCurrent Medical Research and Opinion, 2007
- Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm ProjectPsychological Medicine, 2005
- Third Generation Anticonvulsants in Bipolar DisorderThe Journal of Clinical Psychiatry, 2002
- Clinical guidelines: Developing guidelinesBMJ, 1999